Identification of EGFRvIII-derived CTL Epitopes Restricted by HLA A0201 for Dendritic Cell Based Immunotherapy of Gliomas

By Wu An-hua   Xiao Jing   Anker Lars   Hall Walter   Gregerson Dale   Cavenee Webster   Chen Wei   Low Walter  

Journal of Neuro-Oncology, Vol. 76, Iss. 1, 2006-01 ,pp. : 23-30

Springer Publishing Company

Access to resources Recommend Favorite

Identification of HLA-A*0201-restricted cytotoxic T lymphocyte epitope from proliferating cell nuclear antigen

By Xu Wei  

Tumor Biology, Vol. 32, Iss. 1, 2011-02 ,pp. : 63-69

Springer Publishing Company

Access to resources Recommend Favorite

Identification of a new hTERT-derived HLA-A*0201 restricted, naturally processed CTL epitope

By Thorn Mette   Wang Mingjun   Kløverpris Henrik   Schmidt Esben   Fomsgaard Anders   Wenandy Lynn   Berntsen Annika   Brunak Søren   Buus Søren   Claesson Mogens  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 11, 2007-11 ,pp. : 1755-1763

Springer Publishing Company

Access to resources Recommend Favorite

Targeting the Epidermal Growth Factor Pathway as Therapy for Glioblastoma

By  

Current Cancer Therapy Reviews, Vol. 7, Iss. 1, 2011-02 ,pp. : 65-77

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of a new HLA-A*0201-restricted cytotoxic T lymphocyte epitope from CML28

By Han Jun-Feng   Zhao Ting-Ting   Liu Hong-Li   Lin Zhi-Hua   Wang Hui-Ming   Ruan Zhi-Hua   Zou Li-Yun   Wu Yu-Zhang  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 12, 2006-12 ,pp. : 1575-1583

Springer Publishing Company

Access to resources Recommend Favorite